ADHF and AHF Management In The Emergency Setting

Adams KF, Jr., Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. Feb 2005;149(2):209-216.

Bart BA, Boyle A, Bank AJ, et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol. Dec 6 2005;46(11):2043-2046.

Bayram M, De Luca L, Massie MB, Gheorghiade M. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol. Sep 19 2005;96(6A):47G-58G.

Costanzo MR, Guglin ME, Saltzberg MT, et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. Feb 13 2007;49(6):675-683.

Cuffe MS, Califf RM, Adams KF, Jr., et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA. Mar 27 2002;287(12):1541-1547.

Dar O, Cowie MR. Acute heart failure in the intensive care unit: epidemiology. Crit Care Med. Jan 2008;36 (1 Suppl):S3-8.

DeFrances CJ, Cullen KA, Kozak LJ. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13. Dec 2007(165):1-209.

Didomenico RJ, Perez A, Schumann HM, Fontana DR, Kondos GT, Schumock GT. Impact of Treatment Guidelines on Clinical and Economic Outcomes of Acute Decompensated Heart Failure (March). Ann Pharmacother. Feb 26 2008.

Farrell MH, Foody JM, Krumholz HM. Beta-blockers in heart failure: clinical applications. JAMA. Feb 20 2002;287(7):890-897.

Fonarow GC, Abraham WT, Albert NM, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. Jan 3 2007;297(1):61-70.

Fonarow GC, Adams KF, Jr., Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. Feb 2 2005;293(5):572-580.

Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med. Jul 1985;103(1):1-6.

Gheorghiade M, De Luca L, Fonarow GC, Filippatos G, Metra M, Francis GS. Pathophysiologic targets in the early phase of acute heart failure syndromes. Am J Cardiol. Sep 19 2005;96(6A):11G-17G.

Gheorghiade M, Zannad F, Sopko G, et al. Acute heart failure syndromes: current state and framework for future research. Circulation. Dec 20 2005;112(25):3958-3968.

Gottlieb SS, Brater DC, Thomas I, et al. BG9719 (CVT-124), an A1 Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy. Circulation. 2002;105(11):1348-1353.

Gwadry-Sridhar FH, Flintoft V, Lee DS, Lee H, Guyatt GH. A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Arch Intern Med. Nov 22 2004;164(21):2315-2320.

Hasselblad V, Stough WG, Shah MR, et al. Relation between Diuretic Dose and Outcome in a Heart Failure Population: Results of the ESCAPE Trial. J Card Fail. 2005;11(6):S157.

Heart Failure Society of America. Evaluation and management of patients with acute decompensated heart failure. J Card Fail. Feb 2006;12(1):e86-e103.

Hollenberg SM, Teerlink JR. Acute heart failure: emerging from the shadows. Crit Care Med. Jan 2008;36(1 Suppl):S1-2.

Hugli O, Braun JE, Kim S, Pelletier AJ, Camargo CA, Jr. United States emergency department visits for acute decompensated heart failure, 1992 to 2001. Am J Cardiol. Dec 1 2005;96(11):1537-1542.

Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. Sep 20 2005;112(12):e154-235.

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA. Mar 27 2002;287(12):1531-1540.

Kramer BK, Schweda F, Riegger GA. Diuretic treatment and diuretic resistance in heart failure. Am J Med. Jan 1999;106(1):90-96.

Lindenauer PK, Chehabeddine R, Pekow P, Fitzgerald J, Benjamin EM. Quality of care for patients hospitalized with heart failure: assessing the impact of hospitalists. Arch Intern Med. Jun 10 2002;162(11):1251-1256.

Maisel AS, McCord J, Nowak RM, et al. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol. Jun 4 2003;41(11):2010-2017.

McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis. Mar 2003;41(3):571-579.

Mebazaa A, Nieminen MS, Packer M, et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA. May 2 2007;297(17):1883-1891.

Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA. Feb 6 2002;287(5):628-640.

O'Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M. Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J Card Fail. Apr 2005;11(3):200-205.

Omland T. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure. Crit Care Med. Jan 2008;36(1 Suppl):S17-27.

Onwuanyi A, Taylor M. Acute decompensated heart failure: pathophysiology and treatment. Am J Cardiol. Mar 26 2007;99(6B):25D-30D.

Peacock WF, Albert NM. Patient outcome and costs following an acute heart failure management program in an emergency department observation unit. J Heart Lung Transplant. 1999;18:92.

Peacock WF, Allegra J, Ander D, et al. Management of acute decompensated heart failure in the emergency department. Congest Heart Fail. Sep-Oct 2003;Suppl 1:3-18.

Peacock WF, Emerman CE, Young J, on behalf of the PROACTION Study Group. Safety and efficacy of nesiritide for the treatment of decompensated heart failure in emergency department observation unit patients. J Am Coll Cardiol. 2003;4(suppl A):336A.

Peacock WF, Emerman CL, Costanzo MR, et al. Early initiation of IV vasoactive therapy improves heart failure outcomes: an analysis from the ADHERE registry database. Ann Emerg Med. 2003;42(suppl S):S26.

Peacock WFt, Albert NM. Observation unit management of heart failure. Emerg Med Clin North Am. Feb 2001;19(1):209-232.

Peacock WFt, Remer EE, Aponte J, Moffa DA, Emerman CE, Albert NM. Effective observation unit treatment of decompensated heart failure. Congest Heart Fail. Mar-Apr 2002;8(2):68-73.

Riter HG, Redfield MM, Burnett JC, Chen HH. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction. J Am Coll Cardiol. Jun 6 2006;47(11):2334-2335.

Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. Jan 29 2008;117(4):e25-146.

Silver MA, Maisel A, Yancy CW, et al. BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congest Heart Fail. Sep-Oct 2004;10(5 Suppl 3):1-30.

Yancy CW. Climbing the mountain of acute decompensated heart failure: the EVEREST Trials. JAMA. Mar 28 2007;297(12):1374-1376.

Yilmaz MB, Yalta K, Yontar C, et al. Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine. Cardiovasc Drugs Ther. Dec 2007;21(6):431-435.